Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07695246Recruiting
Randomised, double-blind trial of melatonin in Insomnia (3 arms), sponsored by The University of Hong Kong. Primary endpoint: Insomnia Severity Index at 6 months. Started Aug 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07695246.